PLXNA3 and Hyperkalemia: In previous studies, sex hormone-related side effects (particularly gynecomastia and breast pain) were significantly more common in patients treated with spironolactone compared with eplerenone, and the rate of hyperkalemia was also highest with spironolactone [12, 13].